BlackRock Fund Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$299M Buy
3,248,788
+160,710
+5% +$13.9M 0.06% 398
2016
Q3
$261M Buy
3,088,078
+28,019
+0.9% +$2.35M 0.05% 414
2016
Q2
$249M Buy
3,060,059
+132,250
+5% +$10.1M 0.06% 390
2016
Q1
$209M Buy
2,927,809
+61,940
+2% +$4.15M 0.05% 474
2015
Q4
$204M Sell
2,865,869
-184,369
-6% -$12.4M 0.05% 473
2015
Q3
$187M Buy
3,050,238
+56,267
+2% +$3.93M 0.05% 473
2015
Q2
$217M Buy
2,993,971
+79,129
+3% +$5.84M 0.05% 419
2015
Q1
$224M Buy
2,914,842
+116,010
+4% +$8.31M 0.05% 419
2014
Q4
$188M Buy
2,798,832
+79,292
+3% +$5M 0.05% 483
2014
Q3
$165M Buy
2,719,540
+105,481
+4% +$6.5M 0.05% 490
2014
Q2
$153M Buy
2,614,059
+109,993
+4% +$6.44M 0.04% 563
2014
Q1
$145M Buy
2,504,066
+101,190
+4% +$5.42M 0.04% 563
2013
Q4
$129M Buy
2,402,876
+119,446
+5% +$7.08M 0.04% 655
2013
Q3
$141M Buy
2,283,430
+67,881
+3% +$4.06M 0.05% 505
2013
Q2
$134M Buy
+2,215,549
New +$132M 0.05% 451

Other funds holding DGX

BlackRock Fund Advisors's DGX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Quest Diagnostics (DGX) stake by 5.2% in Q4 2016, buying an estimated $13.9M and bringing the position to 3,248,788 shares worth $299M. The position accounts for 0.06% of the portfolio, ranked #398.

BlackRock Fund Advisors first reported a position in DGX in Q2 2013 and has held it in 15 quarters since. 598 funds tracked by Wall St. Rank hold DGX as of Q4 2016.

  • BlackRock Fund Advisors held 3,248,788 shares of Quest Diagnostics worth $299M as of Q4 2016.
  • BlackRock Fund Advisors bought 160,710 Quest Diagnostics shares in Q4 2016, an estimated $13.9M.
  • Quest Diagnostics made up 0.06% of BlackRock Fund Advisors's portfolio in Q4 2016, its #398 holding.
  • BlackRock Fund Advisors first reported a position in Quest Diagnostics in Q2 2013 and has held it in 15 quarters since.
  • 598 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.